Intracellular receptors
From Proteopedia
(Difference between revisions)
| Line 39: | Line 39: | ||
Residue 270: α:Ile β:Ile γ:Met; Residue 232: α:Ser β:Ala γ:Ala; Residue 395: α:Val β:Val γ:Ala | Residue 270: α:Ile β:Ile γ:Met; Residue 232: α:Ser β:Ala γ:Ala; Residue 395: α:Val β:Val γ:Ala | ||
| - | The <scene name='RA_Mediated_T-reg_Differentiaition/Rxr-ligand_binding_pocket/1'>RXR-alpha binding pocket</scene> is comprised of 16 primarily hydrophobic residues, found on the H3, H5, H7, H11, and L11-12 domains. The ligand used in the crystal, Oleic Acid, is similar to RA, and RA is capable of binding to the RXRα pocket. | + | The <scene name='RA_Mediated_T-reg_Differentiaition/Rxr-ligand_binding_pocket/1'>RXR-alpha binding pocket</scene> is comprised of 16 primarily hydrophobic residues, found on the H3, H5, H7, H11, and L11-12 domains. The ligand used in the crystal, Oleic Acid, is similar to RA, and RA is capable of binding to the RXRα pocket. |
| + | |||
| + | <scene name='51/519788/Cv/2'>Crystal structure of RXRα-DNA complex</scene> (PDB entry [[1by4]]). | ||
| + | When RXRα homodimers assemble on DNA, they form a four poplypeptide complex assembled via head to tail interactions along DR-1 repeated sequences. The | ||
| + | <scene name='RA_Mediated_T-reg_Differentiaition/Rxr_dbd_alpha_helices/1'>alpha helical</scene> structures of the polypeptides sit in the major grooves of the DNA chain, allowing for interaction with specific bases, giving a sequence specificity for the protein. The two <scene name='RA_Mediated_T-reg_Differentiaition/Rxr_dbd_zn_domains/2'>Zinc containing domains</scene> do not alter their configuration upon DNA binding, but are used to guide the DNA into the correct position. Upon binding to DNA, the C-terminal end of the protein, referred to as the <scene name='RA_Mediated_T-reg_Differentiaition/Rxr_dbd_t-box/1'> "T-box" </scene> alters its conformation from alpha helical to an extended conformation. This extended conformation allows Glu74 to move away from the DNA binding pocket and moves it so it interacts with the Zn(II) domain of the next polypeptide. | ||
* [[PPAR-gamma]] | * [[PPAR-gamma]] | ||
* [[Pioglitazone]] is a selective agonist for Peroxisome Proliferator-Activated Receptor Gamma | * [[Pioglitazone]] is a selective agonist for Peroxisome Proliferator-Activated Receptor Gamma | ||
Revision as of 11:46, 19 May 2021
| |||||||||||
References
- ↑ Li MJ, Greenblatt HM, Dym O, Albeck S, Pais A, Gunanathan C, Milstein D, Degani H, Sussman JL. Structure of estradiol metal chelate and estrogen receptor complex: The basis for designing a new class of selective estrogen receptor modulators. J Med Chem. 2011 Apr 7. PMID:21473635 doi:10.1021/jm200192y
